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1998 HD Summary

Number 2

remaining isolations came from captive whitetailed deer and included 1 submission from
Arkansas and 1 from Oklahoma. Presence of
EHDV-2 virus genetic material in affected whitetailed deer, which is detected by the polymerase
chain reaction (PCR) test, was reported for Iowa
and Missouri by state and federal veterinarians
who made additional investigations.

Since 1980, SCWDS has conducted an annual
mail survey of state fish and wildlife agencies and
other selected sources to determine the activity of
hemorrhagic disease (HD) in wild deer and other
big game in the continental United States. HD is
caused by either the epizootic hemorrhagic
disease (EHD) or bluetongue viruses and is the
most important infectious disease syndrome
known in white-tailed deer. The Final Report for
the 1998 Hemorrhagic Disease (HD) Surveillance
Questionnaire has been completed and sent to all
cooperators.
Wildlife biologists and wildlife
health scientists reported that 24 states had HD
activity in a total of 327 counties. Deer die-offs
were reported in Arkansas, Illinois, Iowa, Kansas,
Kentucky, Missouri, Nebraska, South Dakota,
Tennessee,
Virginia,
and
Washington.
Substantial death losses occurred in Illinois, Iowa,
Kentucky, Missouri, Nebraska, and Tennessee.
Several other states have reported focal losses or
evidence of convalescent cases (Alabama,
Indiana, Maryland, Mississippi, North Carolina,
Oklahoma, South Carolina, Texas, and Virginia).

Last year (1998) will be remembered for the
numerous cases of clinical disease in cattle that
were attributable to EHDV. These cattle had
fever, inappetence, lameness, and oral erosions.
Several diagnostic investigations linked the
problem in cattle with EHDV-2 by use of
serology to demonstrate antibodies or the PCR
test to show viral RNA in the blood. However,
the only virus isolation from a bovine was the
aforementioned EHDV-2 from a cow in Missouri.
Wildlife managers should be prepared for
increased speculation on the importance of deer
to the health status of cattle as awareness of
EHDV in cattle develops among farmers.
At this time, we would like to thank all of the
people who participated in the HD survey and/or
submitted virus isolates or samples for virus
isolation during 1998. Copies of the Final Report
are available by request to SCWDS. (Prepared by
Victor Nettles and David Stallknecht)

Eighteen isolations of EHD virus serotype 2
(EHDV-2) were made at SCWDS from August to
November 1998. Nine isolations were made from
samples submitted from Missouri; 8 from whitetailed deer and 1 from a cow. Of the 8 Missouri
deer, 2 were wild and 6 were captive. Isolations
of EHDV-2 also were made from samples
submitted from 3 white-tailed deer from
Tennessee, 1 from Kansas, and 1 from Virginia.
All of these were from free-ranging animals. The

HD Virus Isolation Support
SCWDS provides diagnostic support to our
cooperating agencies through virus isolations of
epizootic hemorrhagic disease virus (EHDV) and
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bluetongue virus (BTV), which are the agents that
cause hemorrhagic disease (HD) in deer. Since
1990, SCWDS has isolated over 70 EHDV-2
viruses as well as several EHDV-1 viruses and a
BT-10 virus from samples submitted throughout
the Southeast and Midwest. With the exception
of last year's EHDV-2 isolation from a Missouri
cow, all of these viruses have come from whitetailed deer.

material for future experimental work to truly
understand the pathogenesis and epidemiology of
these viruses.
With the 1999 HD season (late summer and fall)
approaching, we would like to offer the following
guidelines for submitting samples for virus
isolation:
1. Call SCWDS or the state or federal
diagnostic laboratory that you wish to use
if you have a suspected HD case. Virus
isolation
protocols
vary
among
laboratories, and it is often necessary for
the laboratory to prepare cells for virus
isolation in advance.
2. Tissues collected should include spleen
and, if available from a live animal,
unclotted blood. The blood should be
collected in an anticoagulant such as
EDTA, citrate, or heparin. Anticoagulant
tubes can be obtained from veterinarians or
medical laboratories. HD viruses can be
isolated from other tissues including lung,
lymph node, bone marrow, tongue, liver,
and kidney, but if spleen is available this
single tissue will suffice. Tissue samples
should be kept as clean as possible and
placed in a sealed plastic bag, such as a
Whirl pac or Ziplock bag.
3. Keep all samples cold. DO NOT
FREEZE.
4. Ship the sample overnight, using a wellinsulated package and cold packs. Do not
use wet ice for shipping. Always include
basic information such as the case history
and name and telephone number of the
submitter. Again, consult the laboratory
for specific instructions. At SCWDS, for
example, we are unable to receive packages
over the weekend.

Our virus isolation attempts involve inoculation
of material from a suspect animal into cell
cultures, and we utilize both baby hamster kidney
(BHK21 ) and cattle pulmonary artery endothelial
(CPAE) cell lines. These cell lines are available
from the American Type Culture Collection,
Rockville, MD. With either cell line, two 7-day
passages are done. During 1998, 16 of our
samples were completed in both cell lines. For
these 16 virus isolation attempts, EHDV-2 was
isolated on the CPAE cell line in all cases, while
the virus was isolated in BHK21 cells from only 4.
Similar results were obtained during 1996 when
15 EHDV-2 isolations were made from cases in
which both cell lines were utilized. Of these 15,
virus was isolated from 14 attempts in CPAE
cells but only 5 in BHK21 cells. Although it is
apparent from the above results that the CPAE
cell line offers a much more sensitive EHDV-2
isolation system than BHK21 , we recommend that
both cell lines be used. Had not the BHK 21 cell
line been used in 1996, we would have missed an
EHDV-2 isolation from Indiana and an EHDV-1
isolation from Tennessee.
Considering the
scarcity of EHDV-1 isolates during recent years,
this would have been a significant loss. Another
consideration in utilizing the CPAE cell line is the
fact that this cell line has been reported to be
persistently infected with bovine viral diarrhea
virus. This may render this cell line unsuitable
for use in some diagnostic laboratories and may
complicate the use of CPAE-derived virus
isolations for future experimental work.

Virus isolation is the only way to confirm a case
of HD, but this can be a relatively slow process.
Patience is required; you will be notified of the
results by telephone as soon as they are available.
Virus isolation attempts usually are completed
within 2-3 weeks, but depending on the individual
virus and sample quality, the period required to

We would like to thank all of you who submitted
both virus isolates and samples for virus isolation
during 1998. These isolations not only help to
confirm specific outbreaks, but it is hoped that
they also will provide the necessary biological
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isolate and identify the virus may range from as
short as 10 days to as long as 1 month.
Hopefully, you will not see any HD this year, but
if you do, SCWDS will be more than happy to
continue to assist you in your diagnostic needs.
(Prepared by David Stallknecht)

Another CWD Case in Nebraska
There has been a second confirmation of chronic
wasting disease (CWD) in a captive elk in
Nebraska. This elk was in a captive herd of
approximately 10 animals in Cheyenne County,
near Scottsbluff. It died on April 26, 1999, and
the brain stem was submitted for testing.
Histopathology and the tests for prion protein
were positive. The ranch has been placed under
quarantine by the State Veterinarian's Office, and
a herd plan is being developed which will require
the herd to be under close observation by
personnel with the Nebraska Department of
Agriculture. The Nebraska Game and Parks
Commission will periodically check this herd and
wild elk and deer in the vicinity for clinical signs
of CWD. All captive elk on this newly diagnosed
farm came from a single source herd in Colorado,
which was the same source herd where the first
CWD elk in Nebraska (April 1998) was
diagnosed (SCWDS BRIEFS Vol. 14, No. 1).
There is an investigation underway to determine
if other Nebraska elk herds may have received elk
from this Colorado herd as well. Fortunately,
there were no movements of elk from the affected
Nebraska herd since it was established in March
1997. Nebraska Game and Parks Commission
personnel collected a wild elk that had been
interacting with the captive elk through the fence;
the brainstem from this wild elk was negative for
CWD. Nebraska has strengthened its legislation
on captive cervids, and in the future, the State
Veterinarian will be requiring reporting of all
cervid mortality and CWD testing on all captive
elk over 16 months of age that die. (Prepared by
Victor Nettles)

CWD Survey
This year, SCWDS mailed a questionnaire on
chronic wasting disease (CWD) along with the
annual
Hemorrhagic
Disease
Surveillance
Questionnaire.
Respondents were asked to
identify the numbers of cervids that had been
identified as possible cases and were subjected to
necropsy. The CWD Surveillance Questionnaire
revealed the "dawning of awareness" about this
disease among wildlife managers and animal
health officials. Their responses indicated that
only 26 animals had been examined last year
because they fit the clinical picture of a CWD
"target animal." A CWD target animal is defined
as follows: The classic CWD "suspect" is a deer
or elk 18 months of age or older that is
emaciated and showing some combination of
signs including abnormal behavior, increased
salivation, tremors, stumbling, incoordination,
difficulty in swallowing, excessive thirst, and
excessive urination.
Considering that the
definition of a CWD "target animal" corresponds
well with the generic description of a "sick deer,"
26 cervids is too low. Hopefully, the survey drew
attention to the need to do better.
Some good baseline data are being obtained. We
learned that individuals in 13 states in addition to
Colorado and Wyoming had collected brains
from 1,830 normal wild cervids for surveillance.
Fortunately, the results for wild cervids have been
negative outside the known endemic area in
Colorado and Wyoming. It is hoped that wildlife
biologists and veterinary diagnosticians will make
a greater effort to evaluate deer and elk that fit the
"target profile" for CWD because this will be the
most cost-effective method of surveillance.
SCWDS would like to extend its thanks to the
people who took the time to reply to the surveys.
A copy of the Final Report is available upon
request. (Prepared by Victor Nettles)

Human Lyme Disease Vaccine
SCWDS has received several calls from wildlife
management agency administrators about the new
human Lyme disease vaccine which recently has
become available. SCWDS personnel are not
qualified to become involved in medical
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treatment of humans, and we do not have a
position on the appropriate use of this vaccine.
However, this is an important question because
the safety of agency personnel is a valid
consideration and there is a substantial financial
cost associated with the vaccine.
The Centers for Disease Control and Prevention
(CDC) recently published a brief report entitled
Recommendations for the Use of Lyme Disease
Vaccine (Morbidity and Mortality Weekly Report
Vol. 48/No. RR-7, June 4, 1999). This report
summarized the scientific information pertaining
to the vaccine and gives guidelines for when it
should be deployed. The human vaccine is called
LYMErix®, and vaccination involves 3 injections
at 0, 1, and 12 month intervals. The vaccine
efficacy data given indicate that there was a 49%
protection rate in preventing definite Lyme
disease diagnoses after 2 doses and a 76%
protection after 3 doses. No data are available on
the duration of immunity and need for boosters.

everything else received a low or minimal risk
rating.
In summary, the CDC's Recommendations does
not seem to provide a complete endorsement for
use of the vaccine, but instead, it provides the
available scientific information so that people can
make an informed choice. We would suggest that
wildlife managers seek advice from their state's
public health department, their agency's health
insurance
provider,
and
knowledgeable
physicians before starting a vaccination program
for their personnel. Consult the following CDC
websites for more information:
www.cdc.gov/epo/mmwr/preview/mmwrhtml/rr4
807a1.htm and
www.cdc.gov/epo/mmwr/preview/mmwrhtml/rr4
807a2.htm (Prepared by Victor Nettles)
DEA Tightens Ketamine Use

The report explains that different subpopulations
of humans have different risks of exposure. The
CDC document states, "Most B. burgdorferi
(Lyme disease organism) infections result from
periresidential exposure to infected ticks during
property maintenance, recreation and leisure
activities." It also states, "Persons who engage in
outdoor occupations [e.g., forestry, wildlife and
parks, etc.] in endemic areas might be at elevated
risk for acquiring Lyme Disease."
In a
cost-effectiveness estimate, it was stated that the
"societal cost of vaccination [in this case the cost
to the fish and wildlife agency] exceeds the cost
of not vaccinating, unless the incidence of Lyme
disease
is
greater
than
1,973/100,000
people/year." The cost evaluation is based on the
assumed vaccination cost of $100/person/ year.
This incidence level is higher than the worst
counties known in the endemic New England
states. However, these figures are based on the
general public's exposure rate, which would
include many people who may never see a tick,
and a wildlife biologist or field technician may be
at higher risk. A Lyme disease Risk Map based
on past experience is provided in the report. For
the Southeast, only Maryland and Virginia have
counties in the high or moderate risk ratings;

The Drug Enforcement Administration (DEA) of
the U.S. Department of Justice has published a
Final Rule placing ketamine into Schedule IIIN of
the Controlled Substance Act as a non-narcotic
controlled substance. This Final Notice was
published in the Federal Register (Vol. 64, No.
133, July 13, 1999) and became effective July 2,
1999. Wildlife biologists and veterinarians often
use ketamine (trade names Ketalar, Ketajet,
Ketaset, and Vetalar) to immobilize wild animals,
and this new regulation will have an impact on
how they deploy the drug in the future. The
regulation was enacted because illicit human use
of ketamine has become a serious problem.
Street names for ketamine include "Special K" or
"K."
Major veterinary organizations are
supportive of the regulation.
The new rules require that any person who
manufactures, distributes, dispenses, imports, or
exports ketamine must be registered with the
DEA. This applies also to people who are
engaged in research or conduct instructional
activities with ketamine. Unless a person is
registered with the DEA or has applied for
registration before July 2, 1999, they must
dispose of all stocks of ketamine according to
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DEA guidelines. Alternately, the stocks can be
transferred to a person already registered with the
DEA to possess Schedule III drugs. Ketamine
must be stored under appropriate security in
conformance with DEA regulations, which means
that it must be stored in a locked container.
Furthermore, all packaged ketamine will be
required to have the Schedule III controlled
substance label by April 13, 2000. Stringent use
and inventory record keeping are required, and
prescriptions that have been issued will be limited
to 5 refills and will not be valid after January 13,
2000.

that has been diagnosed in bald eagles, American
coots, and several species of ducks (SCWDS
BRIEFS Vol. 12, No. 4; Vol. 14, No. 3; and Vol.
14, No. 4). ABLS previously was called Coot
and Eagle Brain Lesion Syndrome (CEBLS).
The cause is unknown but is suspected to be a
toxin. The disease was first detected in a highly
publicized die-off of bald eagles in Arkansas in
1994 but now has been diagnosed in bald eagles
and American coots in Arkansas, Georgia, North
Carolina, and South Carolina, as well as in
several species of ducks at 1 location in North
Carolina.

What does this mean for wildlife biologists?
Manufacturers and distributors of ketamine can
only sell to persons holding a DEA Schedule IIIN
registration, so without a registration number
ketamine cannot be purchased. Persons who do
research are eligible to apply for such a
registration and, if registered, would be
responsible for the drugs they purchase and
administer. Without such a personal registration,
the wildlife biologist must obtain the ketamine
from someone who is registered, most likely a
veterinarian acting as an agent on behalf of the
fish and wildlife agency.
Under the latter
arrangement, the veterinarian is ultimately
responsible for tracking the use of the drug even
though the ketamine would be used in the field.
Understandably, many veterinarians will be
reluctant to take that responsibility. People at the
DEA have suggested the possibility of a third
option that would be similar to what is done for
animal control shelters. Here, the state drug
control agency must authorize the obtaining and
dispensing of ketamine. After the state authorizes
this activity, the state wildlife agency can apply to
the DEA to be permitted to purchase and use the
drug under a mid-level practitioner's registration.
For more information, the wildlife biologist
should contact the DEA Registration Section (1800-882-9539 or 202-307-7255). (Prepared by
Victor Nettles)

The original episodes of the disease were
observed in Arkansas, and investigations were
focused on a few reservoir lakes in that state that
had affected birds. In the past 2 years, diagnoses
were made in 3 additional southeastern states, and
therefore, the hypothesis that ABLS was due to
some point-source problem unique to Arkansas
has been abandoned. Concomitant with this
change in perspective has been the need to
address this problem from a regional perspective
as opposed to having a single state carry the lead.
In May, the Arkansas Game and Fish
Commission asked the Steering Committee of the
Southeastern Cooperative Wildlife Disease Study
(SCWDS) for assistance in promoting regional
involvement, and SCWDS was encouraged to
host a workshop to discuss ways for the states to
proceed.
SCWDS will host a Workshop on Avian Brain
Lesion Syndrome that will be held on Thursday,
August 26, 1999, at The University of Georgia's
Center For Continuing Education in Athens, GA.
There will be 3 objectives for the Workshop:
1. To provide field biologists and others with
basic information about ABLS.
2. To receive information from the U.S.
Department of the Interior (Fish and
Wildlife
Service
and/or
Biological
Resources Division of the U.S. Geological
Survey) on their approach to further
investigation (plans being formulated now).

SCWDS Hosts ABLS Workshop
Avian Brain Lesion Syndrome (ABLS) is a term
used to refer to a mysterious neurologic disease
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3.

Force and entered private practice in Savannah,
GA. He returned to military service in 1974 as an
Air Force veterinarian stationed at Camp
Pendleton, CA.

Discuss ways that state fish and wildlife
agencies can contribute to the investigation
to help resolve the problem.

Invitations were sent to all state fish and wildlife
agencies in the Southeast asking them to send
their representatives to participate in this
Workshop. ABLS has implications for both
game and non-game birds, and because the cause
is unknown, wildlife agencies must be prepared to
face speculation from both the scientific sector
and the general public. (Prepared by Victor
Nettles)

With his intense interest in wildlife medicine,
Harold persuaded the Air Force to allow him to
continue his educational pursuits, and in 1979 he
entered a graduate program in wildlife
parasitology with SCWDS. During his research
on the parasites of wild swine for his Master of
Science degree, Harold acquired the affectionate
nickname "Boss Hog" from his coworkers at
SCWDS.

Harold M. Smith -- 1942-1999

While Harold was in the graduate program at
SCWDS, the Air Force terminated its Veterinary
Corps. Undaunted, Harold simply joined the
Army Veterinary Corps to continue his career!
After a couple of years at Ft. Gordon, GA, Harold
realized a life-long dream of living in Alaska. He
was assigned to Ft. Wainwright, AK, as an army
veterinarian responsible for issues involving food
safety, public health, and animal medicine.
During his 5-year tour of duty in Alaska, much of
his off-duty time was devoted to hunting and
fishing in Alaska's wilds. His wife Gee and son
Canada shared equally in his Alaska experience,
just as they did in all aspects of his life.
(Submitted by Col. Paul L. Barrows, U.S. Army
Veterinary Corps, Ft. Sam Houston, San Antonio,
TX)

Dr. Harold M. Smith, Jr. (Lt. Col., Retired),
former SCWDS Research Associate and graduate
student, died July 25, 1999, as a result of
complications following heart by-pass surgery.
Harold was an active member of numerous
professional and sportsmen's groups, and few
could equal his enthusiasm and love for wildlife
both from a vocational and an avocational
perspective. His death is a great loss to the
veterinary profession, the wildlife profession, and
his many friends throughout the country. He will
be greatly missed.
Harold graduated from The University of
Georgia's College of Veterinary Medicine in 1966
and entered the U.S. Air Force Veterinary Corps
shortly thereafter. His first assignment was at
Pease AFB, NH. In 1969 Harold left the Air

*********************************************
Information presented in this Newsletter is not intended for citation in
scientific literature. Please contact the Southeastern Cooperative
Wildlife Disease Study if citable information is needed.
*********************************************
Recent back issues of SCWDS BRIEFS can be accessed on the Internet at SCWDS.org.
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Recent SCWDS Publications Available
Below are some recent publications authored or co-authored by SCWDS staff. If you would like to have a
copy of any of these papers, fill out the request form and return it to us.
____Abdy, M.J., E.W. Howerth, and D.E. Stallknecht. 1999. Experimental infection of cattle with
epizootic hemorrhagic disease virus. American Journal of Veterinary Research 69(5): 621-626.
____Brandsma, A.R., S.E. Little, J.M. Lockhart, W.R. Davidson, D.E. Stallknecht, and J.E. Dawson. 1999.
Novel Ehrlichia organism (Richettsiales: Ehrlichieae) in white-tailed deer associated with lone star
tick (Acari: Ixodidae) parasitism. Journal of Medical Entomology 36(2): 190-194.
____Little, S.E., D.E. Stallknecht, J.M. Lockhart, J.E. Dawson, and W.R. Davidson. 1999. Natural
coinfection of a white-tailed deer (Odocoileus virginianus) population with three Ehrlichia. Journal
of Parasitology 84(5): 897-901.
____Lockhart, J.M. and W.R. Davidson. 1999. Evaluation of C3H/HeJ mice for xenodiagnosis of
infection with Ehrlichia chaffeensis. Journal of Veterinary Diagnostic Investigation 11: 55-59.
____Stallknecht, D.E., E.W. Howerth, C.L. Reeves, and B.S. Seal. 1999. Potential for contact and
mechanical vector transmission of vesicular stomatitis virus New Jersey in pigs. American Journal of
Veterinary Research 60(1): 43-48.
____Van Brackle, M.D., R.L. Marchinton, G.O. Ware, V.F. Nettles, S.B. Linhart, C.D. Ruth, and L.O.
Rogers. 1995. Oral biomarking of a supplementally-fed herd of free-ranging white-tailed deer.
1995 Proceedings of the Southeastern Association of Fish and Wildlife Agencies, pp. 372-381.
____Wlodkowski, J.C. and S.B Linhart. 1998. Raccoon acceptance of a new coated capsule bait. Wildlife
Society Bulletin 26(3): 575-577.
____Little, S.E. and E.W. Howerth. 1999. Ehrlichia chaffeensis in archived tissues of a white-tailed deer.
Journal of Wildlife Diseases 35: 596-599.
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